Stock Market

Analyst Calls: Emami, Aurobindo Pharma, NIACL

Edelweiss Securities has maintained its ‘Hold’ rating on Aurobindo Pharma with a target price of Rs 535.

from Markets-Economic Times https://ift.tt/2OKiTXT

No comments

Powered by Blogger.